- Home
- GOVX vs EJH Comparison
GOVX vs EJH Comparison
Compare GOVX & EJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | EJH |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | China |
| Employees | 19 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 5.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GOVX | EJH |
|---|---|---|
| Price | $1.00 | $2.01 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 306.3K | 6.9K |
| Earning Date | 04-15-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.08 |
| 52 Week High | $4.40 | $3.07 |
Technical Indicators
Market Signals| Indicator | GOVX | EJH |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 67.06 |
| Support Level | $0.96 | $0.78 |
| Resistance Level | $2.00 | $2.80 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 35.22 | 84.45 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
About EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.